Detalhe da pesquisa
1.
Effective treatment with the selective cytokine inhibitor BNZ-1 reveals the cytokine dependency of T-LGL leukemia.
Blood
; 142(15): 1271-1280, 2023 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37352612
2.
Impact of conditioning regimen intensity on the outcomes of peripheral T-cell lymphoma, anaplastic large cell lymphoma and angioimmunoblastic T-cell lymphoma patients undergoing allogeneic transplant.
Br J Haematol
; 197(2): 212-222, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35106754
3.
Clinical outcomes in T-cell large granular lymphocytic leukaemia: prognostic factors and treatment response.
Br J Haematol
; 192(3): 484-493, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32519348
4.
Rapid progression of adult T-cell leukemia/lymphoma as tumor-infiltrating Tregs after PD-1 blockade.
Blood
; 134(17): 1406-1414, 2019 10 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31467059
5.
Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study.
Ann Hematol
; 100(10): 2529-2539, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34304287
6.
Aging Phenotypes and Restoring Functional Deficits in Older Adults With Hematologic Malignancy.
J Natl Compr Canc Netw
; 19(9): 1027-1036, 2021 03 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33770752
7.
Relapse risk and survival in patients with FLT3 mutated acute myeloid leukemia undergoing stem cell transplantation.
Am J Hematol
; 92(4): 331-337, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28052408
8.
Outcomes of Haploidentical Stem Cell Transplantation for Lymphoma with Melphalan-Based Conditioning.
Biol Blood Marrow Transplant
; 22(3): 493-8, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26497906
9.
Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation.
Cancer
; 122(21): 3316-3326, 2016 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27404668
10.
Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation.
Br J Haematol
; 174(2): 235-48, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26989808
11.
Rapid Progression of Adult T-Cell Leukemia-Lymphoma after PD-1 Inhibitor Therapy.
N Engl J Med
; 378(20): 1947-1948, 2018 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29768155
12.
Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplant.
Am J Hematol
; 91(10): E442-7, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27420405
13.
Nonmyeloablative allogeneic hematopoietic stem cell transplant for the treatment of patients with hematologic malignancies using busulfan, fludarabine, and total body irradiation conditioning is effective in an elderly and infirm population.
Biol Blood Marrow Transplant
; 21(1): 89-96, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25445641
14.
Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hematological Malignancies.
Biol Blood Marrow Transplant
; 21(5): 906-12, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25667989
15.
Dual PI3K blockade: PTCL's Achilles heel?
Blood
; 131(8): 839-840, 2018 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29472370
16.
A US Multicenter Collaborative Study on Outcomes of Hematopoietic Cell Transplantation in Hepatosplenic T-Cell Lymphoma.
Transplant Cell Ther
; 30(5): 516.e1-516.e10, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38431075
17.
Post-infusion PD-1+CD8+CAR-T cells identify patients responsive to CD19-CAR-T therapy in non-Hodgkin's lymphoma.
Blood Adv
; 2024 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38607381
18.
The CNS Relapse in T-Cell Lymphoma Index Predicts CNS Relapse in Patients with T- and NK-Cell Lymphomas.
Blood Adv
; 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38739715
19.
Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study.
Blood Adv
; 7(20): 6339-6350, 2023 10 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37530631
20.
Targeting the Inducible T-cell Costimulator (ICOS) in Patients with Relapsed/Refractory T-follicular Helper Phenotype Peripheral T-cell and Angioimmunoblastic T-cell Lymphoma.
Clin Cancer Res
; 29(10): 1869-1878, 2023 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36826995